We are proud to announce the signing of a Memorandum of Understanding (MoU) between the Egyptian Cancer Society (ECS) and AbbVie, aimed at fostering medical innovation and advancing clinical research and companion diagnostics in Egypt.
This partnership reinforces the Society’s pivotal role as a leading scientific reference and the educational arm for oncologists through:
Capacity Building: Tailored training programs to enhance scientific competencies in clinical research.
Innovative Diagnostics: Preparing the healthcare environment for cutting-edge solid tumor treatments through specialized educational initiatives.
Sustainability: Establishing a world-class framework for future clinical trials within Egypt.
In the presence of ECS board members: Prof. Hesham Elghazaly, Prof. Heba ELzawahry, Prof. Emad Hamada, Prof. Gamal Amira, Prof. Nehal AlMashad and Prof. Emad Shash.
The collaboration kicked off with the Ovarian Cancer Scientific Day, featuring a distinguished panel of experts discussing the latest treatment landscapes and clinical case studies led by experts:
Prof. Ahmed Sekotory, Prof. Hussam Zawan and Dr. Asmaa Ali
Together, we are committed to transforming patient lives and elevating the Egyptian healthcare system through science and innovation.
